Limited Competition for the Continuation of Rare Diseases Clinical Research Consortia in the Rare Diseases Clinical Research Network (U54)

The summary for the Limited Competition for the Continuation of Rare Diseases Clinical Research Consortia in the Rare Diseases Clinical Research Network (U54) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Limited Competition for the Continuation of Rare Diseases Clinical Research Consortia in the Rare Diseases Clinical Research Network (U54): The purpose of this limited competition Funding Opportunity Announcement (FOA) is to provide an opportunity for the NINDS American Recovery and Reinvestment Act (ARRA)-funded consortia to compete for another three years of participation in the Rare Diseases Clinical Research Network (RDCRN). The RDCRN is a collaborative and coordinated network of Clinical Research Consortia comprised of investigators and patient support groups committed to investigation of rare diseases working in partnership with the Data Management Coordinating Center to enhance communication and sharing of resources in a multidisciplinary approach. The RDCRN is focused on 1) the collection of clinical information to better define disease natural history and to develop biomarkers as well as new approaches to diagnosis, prevention, and treatment of rare diseases, and 2) training of new clinical investigators in rare diseases research.
Federal Grant Title: Limited Competition for the Continuation of Rare Diseases Clinical Research Consortia in the Rare Diseases Clinical Research Network (U54)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-11-187
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.853
CFDA Descriptions: Extramural Research Programs in the Neurosciences and Neurological Disorders
Current Application Deadline: Jun 15, 2011
Original Application Deadline: Jun 15, 2011
Posted Date: Mar 31, 2011
Creation Date: Mar 31, 2011
Archive Date: Jul 16, 2011
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Only currently active NINDS Rare Diseases Consortia are eligible to apply.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/par-11-187.html
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Mechanistic Basis of Diffuse White Matter Disease in Vascular Contributions to Cognitive I...
Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01)
NINDS Institutional Center Core Grants to Support Neuroscience Research (P30)
Centers Without Walls for Collaborative Research in the Epilepsies: Developing Transformat...
Child Neurologist Career Development Program (CNCDP) (K12)
NINDS Cooperative Small Business Awards In Translational Research (SBIR/U44)
NINDS Institutional Center Core Grants to Support Neuroscience Research
Career Development Award to Promote Diversity in Neuroscience Research
More Grants from the National Institutes of Health
T4 Translation Research Capacity Building Initiative in Low Income Countries (TREIN) (U24)
Cooperative Research Agreements Related to the World Trade Center Health Program (U01)
NARMS Cooperative Agreement Program to Enhance and Strengthen Antibiotic Resistance Survei...
Accelerating Research on Intervertebral Disc (ARID) (R01)
Accelerating Research on Intervertebral Disc (ARID) (R21)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2016 FederalGrants.com